Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan van der Heyden

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
Journal of the American College of Cardiology|May 16, 2019
Permanent Percutaneous Carotid Artery Filter to Prevent Stroke in Atrial Fibrillation Patients: The CAPTURE TrialVivek Y Reddy, Petr Neuzil, Tom de Potter, et al.
Circulation. Cardiovascular Imaging|May 10, 2017
Early Detection and Treatment of the Vulnerable Coronary Plaque: Can We Prevent Acute Coronary Syndromes?Michiel J Bom, Dirk J van der Heijden, Elvin Kedhi, et al.
JACC. Cardiovascular Interventions|February 11, 2022
Treatment of Resistant Hypertension With Endovascular Baroreflex Amplification: 3-Year Results From the CALM-FIM StudyMonique E A M van Kleef, Chandan M Devireddy, Jan van der Heyden, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|December 27, 2018
Impact of mitral valve treatment choice on mortality according to aetiologyFriso Kortlandt, Juliette Velu, Remco Schurer, et al.
Circulation|October 17, 2007
Staged carotid angioplasty and stenting followed by cardiac surgery in patients with severe asymptomatic carotid artery stenosis: early and long-term resultsJan Van der Heyden, Maarten J Suttorp, Egbert T Bal, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|March 18, 2015
Real-world experience with a novel biodegradable polymer sirolimus-eluting stent: twelve-month results of the BIOFLOW-III registryJohannes Waltenberger, Johannes Brachmann, Jan van der Heyden, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|March 30, 2019
Five-Year Results of the Bioflow-III Registry: Real-World Experience with a Biodegradable Polymer Sirolimus-Eluting StentJohannes Waltenberger, Johannes Brachmann, Jan van der Heyden, et al.
Lancet (London, England)|September 6, 2017
Endovascular baroreflex amplification for resistant hypertension: a safety and proof-of-principle clinical studyWilko Spiering, Bryan Williams, Jan Van der Heyden, et al.
Journal of the American College of Cardiology|November 15, 2011
Correction of mitral regurgitation in nonresponders to cardiac resynchronization therapy by MitraClip improves symptoms and promotes reverse remodelingAngelo Auricchio, Wolfgang Schillinger, Sven Meyer, et al.
Lancet (London, England)|March 31, 2016
A transcatheter intracardiac shunt device for heart failure with preserved ejection fraction (REDUCE LAP-HF): a multicentre, open-label, single-arm, phase 1 trialGerd Hasenfuß, Chris Hayward, Dan Burkhoff, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Journal of the American College of Cardiology|May 16, 2019
Permanent Percutaneous Carotid Artery Filter to Prevent Stroke in Atrial Fibrillation Patients: The CAPTURE TrialVivek Y Reddy, Petr Neuzil, Tom de Potter, et al.
Circulation. Cardiovascular Imaging|May 10, 2017
Early Detection and Treatment of the Vulnerable Coronary Plaque: Can We Prevent Acute Coronary Syndromes?Michiel J Bom, Dirk J van der Heijden, Elvin Kedhi, et al.
JACC. Cardiovascular Interventions|February 11, 2022
Treatment of Resistant Hypertension With Endovascular Baroreflex Amplification: 3-Year Results From the CALM-FIM StudyMonique E A M van Kleef, Chandan M Devireddy, Jan van der Heyden, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|December 27, 2018
Impact of mitral valve treatment choice on mortality according to aetiologyFriso Kortlandt, Juliette Velu, Remco Schurer, et al.
Circulation|October 17, 2007
Staged carotid angioplasty and stenting followed by cardiac surgery in patients with severe asymptomatic carotid artery stenosis: early and long-term resultsJan Van der Heyden, Maarten J Suttorp, Egbert T Bal, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|March 18, 2015
Real-world experience with a novel biodegradable polymer sirolimus-eluting stent: twelve-month results of the BIOFLOW-III registryJohannes Waltenberger, Johannes Brachmann, Jan van der Heyden, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|March 30, 2019
Five-Year Results of the Bioflow-III Registry: Real-World Experience with a Biodegradable Polymer Sirolimus-Eluting StentJohannes Waltenberger, Johannes Brachmann, Jan van der Heyden, et al.
Lancet (London, England)|September 6, 2017
Endovascular baroreflex amplification for resistant hypertension: a safety and proof-of-principle clinical studyWilko Spiering, Bryan Williams, Jan Van der Heyden, et al.
Journal of the American College of Cardiology|November 15, 2011
Correction of mitral regurgitation in nonresponders to cardiac resynchronization therapy by MitraClip improves symptoms and promotes reverse remodelingAngelo Auricchio, Wolfgang Schillinger, Sven Meyer, et al.
Lancet (London, England)|March 31, 2016
A transcatheter intracardiac shunt device for heart failure with preserved ejection fraction (REDUCE LAP-HF): a multicentre, open-label, single-arm, phase 1 trialGerd Hasenfuß, Chris Hayward, Dan Burkhoff, et al.
Pageof 4